NVIC Articles

vaccine-injury

Disease-Vaccine-Landing-Page/Meningitis/vaccine-injury

Latest articles

Browse Articles

Placeholder image
Page

In addition to reactions and injuries following meningococcal vaccination, administration errors resulting in adverse events have also been reported. Menactra (MCV4/MenACWY-D) meningococcal conjugate vaccine is approved to be administered intramuscularly...

Placeholder image
Page

As of December 27, 2024, there have been 49,696 reports of meningococcal vaccine reactions, hospitalizations, injuries and deaths following meningococcal vaccinations made to the federal Vaccine Adverse Events Reporting System...

Placeholder image
Page

In clinical trials of Pfizer’s PENBRAYA pentavalent meningococcal vaccine, trial participants received either a dose of PENBRAYA meningococcal vaccine (MenABCWY) or meningococcal (serogroups A, C, W and Y) oligosaccharide diphtheria...

Placeholder image
Page

According to the CDC, more than 50 percent of meningococcal serogroup B (BEXSERO or TRUMENBA) vaccine recipients experience mild side effects that may include pain, redness, and swelling to the...

Placeholder image
Page

According to the CDC, individuals receiving meningococcal vaccines targeting meningococcal serogroups A, C, Y, and W-135 (Menactra or Menveo) may experience mild side effects such as pain or redness at...

Topics
Select disease / vaccine